Johnson Matthey PLC (LON:JMAT – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,623.91 ($20.22) and traded as high as GBX 1,782 ($22.18). Johnson Matthey shares last traded at GBX 1,767 ($22.00), with a volume of 291,103 shares traded.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on JMAT shares. Berenberg Bank lifted their price target on shares of Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research report on Monday, April 8th. Numis Securities reaffirmed a “buy” rating and issued a GBX 2,200 ($27.39) price objective on shares of Johnson Matthey in a research report on Wednesday, March 20th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,100 ($26.14) price objective on shares of Johnson Matthey in a research report on Wednesday, March 20th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 2,010 ($25.02).
Get Our Latest Stock Report on JMAT
Johnson Matthey Stock Down 0.9 %
Insider Activity at Johnson Matthey
In related news, insider Stephen Oxley purchased 24 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The shares were acquired at an average price of GBX 1,597 ($19.88) per share, for a total transaction of £383.28 ($477.13). In the last 90 days, insiders have purchased 66 shares of company stock worth $114,288. Insiders own 0.60% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- What Investors Need to Know to Beat the Market
- Comprehensive PepsiCo Stock Analysis
- Investing in Travel Stocks Benefits
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Ride Out The Recession With These Dividend Kings
- Bear Market Funds to Watch This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.